SOSUM PCL SOLUTION
SOSUM PCL SOLUTION it’s collagen regenerative cosmetic of which main ingredient is polycaprolactone (PCL) It is intended to be used for a facial tissu
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Others,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Other Beauty Equipment
Celset Co., Ltd.
- Membership
- PRO
- Recent Visit
- Nov 06, 2024
- Country / Year Established
- South Korea /
- Business type
- Others
- Verified Certificate
-
2
Product name | SOSUM PCL SOLUTION | Certification | - |
---|---|---|---|
Category | Other Beauty Equipment | Material | - |
Keyword | injection , pdrn | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | 1000 |
Supply type | Available | HS code | - |
Product Information
SOSUM PCL SOLUTION it’s collagen regenerative cosmetic of which main ingredient is polycaprolactone (PCL)
It is intended to be used for a facial tissue augmentation for intradermal implantation to correct defect of soft tissue.
INGREDIENTS IN PCL SOLUTION
Water, Glycerin, PEG-20, Polycaprolactone, Sodium Hyaluronate.
WHAT IS PCL?
Polycaprolactone (PCL) is a biodegradable and biocompatible synhetic polymer. It individually posesses an excellent and proven safety-biocompatibility profile.
PCL is not only biodegradable but it is totally bioresorbable as the final degradation process leads to the total elimination of the non-toxic degradation by-products, CO2 and H2O from the body.
This is proven through decades of extensive documented evidence from scientific literature and tes results.
PCL has been classified by the US FDA as Generally Recognized As Safe (GRAS) substances and approved by the US FDA and CE as safe to use in numerous medical devices in humans.
PCL has already been used successfully world-wide since the 1950’s as a medical device in a wide variety of forms: microspheres, nanoparticles, films, fibres, micelles, scaffolds, fillers, etc.
EFFICACY OF PCL
After being injected in the body, PCL is encapsues by collagen presents in the body, escapes from phagocytosis, and then induces neo-collagenesis.
PCL has already been shown to have neo-collagenesis ability through global clinical trials and is currently degrading slowly following procedure and simultaneously initiates collagenesis.
PCL induces neo-collagenesis within about 12 months.
B2B Trade
Price (FOB) | Negotiable | transportation | Negotiation Other |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Others,T/T | Shipping time | Negotiable |
- President
- Product Category
- Medical Devices
- Main Markets
-
Indonesia
Philippines
Russia
Thailand
- Main Product